Cubist Pharmaceuticals, Inc. (NASDAQ:CBST)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.

Recs

1
Player Avatar timattox (99.27) Submitted: 4/24/2010 2:50:32 PM : Outperform Start Price: $22.70 CBST Score: +67.23

From my ValueGrowth screen

Featured Broker Partners


Advertisement